Quantitative determination of buagafuran in human plasma by liquid chromatography-tandem mass spectrometry

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Jun 15;879(20):1789-94. doi: 10.1016/j.jchromb.2011.04.029. Epub 2011 May 6.

Abstract

A sensitive and selective high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method was developed for the determination of buagafuran in human plasma. The analyte was extracted from plasma samples with hexane after addition of isotopic internal standard and chromatographed on a RP-C(8) column. The mobile phase consisted of methanol-water (90:10, v/v) and the flow rate was 0.2 mL/min. The detection was performed on a triple quadrupole tandem mass spectrometer in multiple reactions monitoring (MRM) mode using positive electrospray ionization (ESI). The method was validated over the concentration range of 0.5-200 ng/mL. Inter- and intra-day precision (RSD%) were all within 15% and the accuracy (RE%) was equal or lower than 9.5%. The lower limit of quantitation (LLOQ) was 0.5 ng/mL. The extraction recovery was on average 38.1% and the detection was not affected by the matrix. The method was successfully applied to the pharmacokinetic study of buagafuran in healthy Chinese volunteers.

Publication types

  • Clinical Trial, Phase I
  • Randomized Controlled Trial

MeSH terms

  • Anti-Anxiety Agents / blood
  • Anti-Anxiety Agents / pharmacokinetics
  • Chromatography, High Pressure Liquid / methods*
  • Cross-Over Studies
  • Dose-Response Relationship, Drug
  • Drug Stability
  • Humans
  • Linear Models
  • Male
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Sesquiterpenes / blood*
  • Sesquiterpenes / pharmacokinetics
  • Tandem Mass Spectrometry / methods*

Substances

  • Anti-Anxiety Agents
  • Sesquiterpenes
  • buagafuran